Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma

Eur J Cancer Clin Oncol. 1989 Nov;25(11):1651-2. doi: 10.1016/0277-5379(89)90312-x.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Organophosphorus Compounds / adverse effects
  • Organophosphorus Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • fotemustine